Novel LRRK2 Kinase Inhibitors Enhance Phosphorylation and Restore Adapter Protein Binding in LRRK2 Variants
Albert William Garofalo, Marcus D. Schonemann, Matteo Santoro, Marc Adler, Thomas Jude Montine
This study evaluates two series of LRRK2 inhibitors, showing that series B compounds enhance phosphorylation and restore 14-3-3 binding in LRRK2 variants, suggesting conformation-selective inhibition as a potential PD therapy.
bioRxiv · Oct 28, 2026 · PreprintBiochemistry